Hanie Mahaki

Hanie Mahaki


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 November 2021 in Future Virology
Verified
Journal Article
Open access
MSMaryam Shafaati
Maryam Shafaati
MSMassoud Saidijam
Massoud Saidijam
MSMeysam Soleimani
Meysam Soleimani
FHFereshte Hazrati
Fereshte Hazrati
RMRasoul Mirzaei
Rasoul Mirzaei
Mohammad AhmadyousefiMohammad Ahmadyousefi
Mohammad Ahmadyousefi
This article provides a brief overview of DNA vaccines. First, the basic DNA vaccine design strategies are described, then specific issues related to the industrial production of DNA vaccines are d...

17 August 2023 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HTHamid Tanzadehpanah
Hamid Tanzadehpanah
ELElham Lotfian
Elham Lotfian
AAAmir Avan
Amir Avan
SSSahar Saki
Sahar Saki
SNSima Nobari
Sima Nobari
HMHanie Mahaki
Hanie Mahaki
The occurrence of a novel coronavirus known as severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has high infectivity, the ability to be transmitted even during the asymptomatic phase, and relatively low virulence, which has resulted in rapid transmission. SARS-CoV-2 can invade epithelial cells, hence, many patients infected with SARS-CoV-2 have suffered from vascular diseases (VDs) in addition to pulmonary manifestations. Accordingly, SARS-CoV-2 may can worsen the clinical condition of the patients with pre-existing VDs. Endothelial cells express angiotensin-converting enzyme 2 (ACE2). ACE2 is a biological enzyme that converts angiotensin (Ang)- 2 to Ang-(1-7). SARS-CoV-2 uses ACE2 as a cell receptor for viral entry. Thus, the SARS-CoV-2 virus promotes downregulation of ACE2, Ang-(1-7), and anti-inflammatory cytokines, as well as, an increase in Ang-2, resulting in pro-inflammatory cytokines. SARS-CoV-2 infection can cause hypertension, and endothelial damage, which can lead to intravascular thrombosis. In this review, we have concentrated on the effect of SARS-CoV-2 in peripheral vascular diseases (PVDs) and ACE2 as an enzyme in Renin-angiotensin aldosterone system (RAAS). A comprehensive search was performed on PubMed, Google Scholar, Scopus, using related keywords. Articles focusing on ("SARS-CoV-2", OR "COVID-19"), AND ("Vascular disease", OR "Peripheral vascular disease", OR interested disease name) with regard to MeSH terms, were selected. According to the studies, it is supposed that vascular diseases may increase susceptibility to severe SARS-CoV-2 infection due to increased thrombotic burden and endothelial dysfunction. Understanding SARS-CoV-2 infection mechanism and vascular system pathogenesis is crucial for effective management and treatment in pre-existing vascular diseases.

1 February 2013 in Journal of Luminescence
Verified
Journal Article
Closed access
HMHanie Mahaki
Hanie Mahaki
MMMina Memarpoor-Yazdi
Mina Memarpoor-Yazdi
JCJamshidkhan Chamani
Jamshidkhan Chamani
MSMohammad Reza Saberi
Mohammad Reza Saberi

22 December 2022 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
MSMohsen Sheykhhasan
Mohsen Sheykhhasan
HTHamid Tanzadehpanah
Hamid Tanzadehpanah
AAAmirhossein Ahmadieh-Yazdi
Amirhossein Ahmadieh-Yazdi
HMHanie Mahaki
Hanie Mahaki
RSReihaneh Seyedebrahimi
Reihaneh Seyedebrahimi
PDPaola Dama
Paola Dama
(1) Background: Mounting evidence supports the idea that one of the most critical agents in controlling gene expression could be long non-coding RNAs (lncRNAs). Upregulation of lncRNA is observed in the different processes related to pathologies, such as tumor occurrence and development. Among the crescent number of lncRNAs discovered, FLVCR1-AS1 and FBXL19-AS1 have been identified as oncogenes in many cancer progression and prognosis types, including cholangiocarcinoma, gastric cancer, glioma and glioblastoma, hepatocellular carcinoma, lung cancer, ovarian cancer, breast cancer, colorectal cancer, and osteosarcoma. Therefore, abnormal FBXL19-AS1 and FLVCR1-AS1 expression affect a variety of cellular activities, including metastasis, aggressiveness, and proliferation; (2) Methods: This study was searched via PubMed and Google Scholar databases until May 2022; (3) Results: FLVCR1-AS1 and FBXL19-AS1 participate in tumorigenesis and have an active role in impacting several signaling pathways that regulate cell proliferation, migration, invasion, metastasis, and EMT; (4) Conclusions: Our review focuses on the possible molecular mechanisms in a variety of cancers regulated by FLVCR1-AS1 and FBXL19-AS1. It is not surprising that there has been significant interest in the possibility that these lncRNAs might be used as biomarkers for diagnosis or as a target to improve a broader range of cancers in the future.

6 February 2025 in Regenerative Therapy
Verified
Journal Article
Open access
HTHamid Tanzadehpanah
Hamid Tanzadehpanah
SNSima Nobari
Sima Nobari
AHAva Jalalian Hoseini
Ava Jalalian Hoseini
FGFarzaneh Ghotbani
Farzaneh Ghotbani
MMMohsen Mehrabzadeh
Mohsen Mehrabzadeh
HMHanie Mahaki
Hanie Mahaki
Platelet-rich plasma (PRP) is a promising regenerative therapy due to its simplicity, clinical application, safety, and ability to promote angiogenesis. It utilizes various angiogenic growth factors in platelets, including platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β), insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), and epidermal growth factor (EGF), which are integral to the tissue repair. Critical limb ischemia (CLI) is a major symptom of peripheral arterial disease (PAD), and PRP therapy aims to improve blood circulation to the distal limb through the development of blood vessels. This review focuses on the extensive research on the molecular mechanisms of PRPs in treating CLI. A comprehensive search was conducted on Web of Science, PubMed, Google Scholar, and Scopus to find studies published during PRP therapy in critical limb ischemia up to June 2024. Current studies reveal that PRP composition varies by case, affecting preparation methods, storage duration, storage methods, and interaction with other materials. PRP-derived growth factors have shown promising results in treating CLI, but well-controlled human research is scarce despite positive animal studies.

28 June 2023 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
HTHamid Tanzadehpanah
Hamid Tanzadehpanah
MMMohammad Hadi Saeed Modaghegh
Mohammad Hadi Saeed Modaghegh
HMHanie Mahaki
Hanie Mahaki